相似文献
1
Should EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition?
J Cancer. 2014 Jan 15;5(2):125-32. doi: 10.7150/jca.8242. eCollection 2014.
2
The Epithelial-Myeloid-Transition (EMyeT) of cancer cells as a wrongly perceived primary inflammatory process eventually progressing to a bone remodeling malignancy: the alternative pathway for Epithelial- Mesenchymal-Transition hypothesis (EMT)?
J Cancer. 2019 Jun 9;10(16):3798-3809. doi: 10.7150/jca.31364. eCollection 2019.
3
Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition.
Pathol Oncol Res. 2021 Apr 30;27:609472. doi: 10.3389/pore.2021.609472. eCollection 2021.
4
TGF-β1-Induced Epithelial-Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells.
Front Oncol. 2015 Jan 26;5:3. doi: 10.3389/fonc.2015.00003. eCollection 2015.
5
Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells.
Stem Cells. 2010 Aug;28(8):1435-45. doi: 10.1002/stem.467.
6
Perspectives on the mesenchymal origin of metastatic cancer.
Cancer Metastasis Rev. 2010 Dec;29(4):695-707. doi: 10.1007/s10555-010-9254-z.
7
Ionizing Radiation Promotes Epithelial-to-Mesenchymal Transition in Lung Epithelial Cells by TGF-β-producing M2 Macrophages.
In Vivo. 2019 Nov-Dec;33(6):1773-1784. doi: 10.21873/invivo.11668.
8
Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
Adv Exp Med Biol. 2017;994:229-245. doi: 10.1007/978-3-319-55947-6_12.
9
Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Theranostics. 2020 Jul 9;10(18):8365-8381. doi: 10.7150/thno.45395. eCollection 2020.
10
Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Hum Reprod. 2016 Apr;31(4):734-49. doi: 10.1093/humrep/dew018. Epub 2016 Feb 22.
引用本文的文献
1
The Warburg hypothesis and the emergence of the mitochondrial metabolic theory of cancer.
J Bioenerg Biomembr. 2025 Apr 8. doi: 10.1007/s10863-025-10059-w.
2
You complete me: tumor cell-myeloid cell nuclear fusion as a facilitator of organ-specific metastasis.
Front Oncol. 2023 Jun 22;13:1191332. doi: 10.3389/fonc.2023.1191332. eCollection 2023.
3
Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition.
Pathol Oncol Res. 2021 Apr 30;27:609472. doi: 10.3389/pore.2021.609472. eCollection 2021.
4
Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer.
Front Nutr. 2020 Mar 11;7:21. doi: 10.3389/fnut.2020.00021. eCollection 2020.
5
The Epithelial-Myeloid-Transition (EMyeT) of cancer cells as a wrongly perceived primary inflammatory process eventually progressing to a bone remodeling malignancy: the alternative pathway for Epithelial- Mesenchymal-Transition hypothesis (EMT)?
J Cancer. 2019 Jun 9;10(16):3798-3809. doi: 10.7150/jca.31364. eCollection 2019.
6
Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types.
J Immunol Res. 2018 Oct 29;2018:5804230. doi: 10.1155/2018/5804230. eCollection 2018.
7
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.
J Clin Invest. 2018 Dec 3;128(12):5505-5516. doi: 10.1172/JCI98060. Epub 2018 Nov 5.
8
Corneal Epithelial Cells Exhibit Myeloid Characteristics and Present Antigen via MHC Class II.
Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1512-1522. doi: 10.1167/iovs.17-23279.
9
MiR-29b/TET1/ZEB2 signaling axis regulates metastatic properties and epithelial-mesenchymal transition in breast cancer cells.
Oncotarget. 2017 Oct 31;8(60):102119-102133. doi: 10.18632/oncotarget.22183. eCollection 2017 Nov 24.
10
Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies.
Mediators Inflamm. 2016;2016:9012369. doi: 10.1155/2016/9012369. Epub 2016 Feb 14.
本文引用的文献
1
The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective.
Cancer Manag Res. 2013 Jul 31;5:187-95. doi: 10.2147/CMAR.S35171. eCollection 2013.
2
Pronounced cancer resistance in a subterranean rodent, the blind mole-rat, Spalax: in vivo and in vitro evidence.
BMC Biol. 2013 Aug 9;11:91. doi: 10.1186/1741-7007-11-91.
3
Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies.
Clin Cancer Res. 2013 Oct 1;19(19):5340-50. doi: 10.1158/1078-0432.CCR-12-3685. Epub 2013 Aug 6.
4
Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer.
Oral Oncol. 2013 Sep;49(9):854-862. doi: 10.1016/j.oraloncology.2013.06.010. Epub 2013 Jul 19.
5
Osteoclast precursors in murine bone marrow express CD27 and are impeded in osteoclast development by CD70 on activated immune cells.
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12385-90. doi: 10.1073/pnas.1216082110. Epub 2013 Jul 5.
6
Breast cancer expression of DAP12 is associated with skeletal and liver metastases and poor survival.
Clin Breast Cancer. 2013 Oct;13(5):371-7. doi: 10.1016/j.clbc.2013.05.003. Epub 2013 Jun 27.
7
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer.
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11091-6. doi: 10.1073/pnas.1222251110. Epub 2013 Jun 17.
8
Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers.
Mol Cancer. 2013 Jun 12;12:60. doi: 10.1186/1476-4598-12-60.
9
Stem cell properties in cell cultures from different stage of melanoma progression.
Appl Immunohistochem Mol Morphol. 2014 Mar;22(3):171-81. doi: 10.1097/PAI.0b013e31828ff701.
10
Expression of Lewis X is associated with poor prognosis in triple-negative breast cancer.
Am J Clin Pathol. 2013 Jun;139(6):746-53. doi: 10.1309/AJCP2E6QNDIDPTTC.
Zotero 插件